Erfei Luo

1.5k total citations · 1 hit paper
29 papers, 1.0k citations indexed

About

Erfei Luo is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Erfei Luo has authored 29 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 9 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Erfei Luo's work include Acute Kidney Injury Research (6 papers), Acute Myocardial Infarction Research (5 papers) and Cardiac Imaging and Diagnostics (4 papers). Erfei Luo is often cited by papers focused on Acute Kidney Injury Research (6 papers), Acute Myocardial Infarction Research (5 papers) and Cardiac Imaging and Diagnostics (4 papers). Erfei Luo collaborates with scholars based in China, Germany and United Kingdom. Erfei Luo's co-authors include Gaoliang Yan, Chengchun Tang, Yong Qiao, Jiantong Hou, Yuhan Qin, Linqing Li, Dong Wang, Dong Wang, Bo Liu and Yuyu Yao and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Experimental Cell Research and Life Sciences.

In The Last Decade

Erfei Luo

26 papers receiving 998 citations

Hit Papers

Role of m6A RNA methylation in cardiovascular disease (Re... 2020 2026 2022 2024 2020 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Role of m6A RNA methylation in cardiovascular disease (Review)
    2020 205 citations Yuhan Qin, Linqing Li et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erfei Luo China 15 506 257 237 190 182 29 1.0k
Jiantong Hou China 12 410 0.8× 257 1.0× 195 0.8× 155 0.8× 178 1.0× 30 837
Bernd Hewing Germany 18 317 0.6× 151 0.6× 442 1.9× 241 1.3× 86 0.5× 33 1.3k
Eiichiro Yamamoto Japan 14 290 0.6× 214 0.8× 337 1.4× 189 1.0× 56 0.3× 34 946
Bin Liang China 15 416 0.8× 387 1.5× 186 0.8× 95 0.5× 175 1.0× 40 1.1k
Lihua Ni China 12 390 0.8× 151 0.6× 91 0.4× 200 1.1× 248 1.4× 39 828
Dachun Xu China 19 459 0.9× 206 0.8× 496 2.1× 110 0.6× 290 1.6× 50 1.4k
Yi Song China 19 456 0.9× 170 0.7× 81 0.3× 75 0.4× 231 1.3× 88 1.1k
Nada Cordasic Germany 21 299 0.6× 93 0.4× 306 1.3× 181 1.0× 111 0.6× 48 1.0k
Kevin R. Regner United States 20 371 0.7× 157 0.6× 99 0.4× 78 0.4× 101 0.6× 49 1.0k
Hailing Li China 16 336 0.7× 141 0.5× 210 0.9× 66 0.3× 61 0.3× 56 907

Countries citing papers authored by Erfei Luo

Since Specialization
Citations

This map shows the geographic impact of Erfei Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erfei Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erfei Luo more than expected).

Fields of papers citing papers by Erfei Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erfei Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erfei Luo. The network helps show where Erfei Luo may publish in the future.

Co-authorship network of co-authors of Erfei Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Erfei Luo. A scholar is included among the top collaborators of Erfei Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erfei Luo. Erfei Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cuthbert, Joseph J., Erfei Luo, Hugh R. Butt, et al.. (2025). Rationale and design of the ADA-HF (Acetazolamide as a chloride sparing Diuretic in patients Admitted with Heart Failure) trial. European Heart Journal Open. 5(2). oeaf019–oeaf019.
2.
3.
Luo, Erfei, et al.. (2023). Cardiac magnetic resonance imaging for preprocedural planning of percutaneous left atrial appendage closure. Frontiers in Cardiovascular Medicine. 10. 1132626–1132626. 2 indexed citations
4.
Li, Linqing, Yuhan Qin, Erfei Luo, et al.. (2022). Elevated TyG Index Predicts Incidence of Contrast-Induced Nephropathy: A Retrospective Cohort Study in NSTE-ACS Patients Implanted With DESs. Frontiers in Endocrinology. 13. 817176–817176. 15 indexed citations
5.
Rottbauer, Wolfgang, Volker Rasche, Dominik Buckert, et al.. (2022). Computed tomography angiography/magnetic resonance imaging-based preprocedural planning and guidance in the interventional treatment of structural heart disease. Frontiers in Cardiovascular Medicine. 9. 931959–931959. 2 indexed citations
6.
Luo, Erfei, Hongxia Li, Yuhan Qin, et al.. (2021). Role of ferroptosis in the process of diabetes-induced endothelial dysfunction. World Journal of Diabetes. 12(2). 124–137. 112 indexed citations
7.
Qin, Yuhan, Gaoliang Yan, Dong Wang, et al.. (2021). A High Triglyceride-Glucose Index Is Associated With Contrast-Induced Acute Kidney Injury in Chinese Patients With Type 2 Diabetes Mellitus. Frontiers in Endocrinology. 11. 522883–522883. 36 indexed citations
8.
Qin, Yuhan, Yong Qiao, Linqing Li, et al.. (2021). The m6A methyltransferase METTL3 promotes hypoxic pulmonary arterial hypertension. Life Sciences. 274. 119366–119366. 76 indexed citations
9.
10.
11.
Tang, Chengchun, Dong Wang, Erfei Luo, et al.. (2020). Activation of Inward Rectifier K+ Channel 2.1 by PDGF‐BB in Rat Vascular Smooth Muscle Cells through Protein Kinase A. BioMed Research International. 2020(1). 4370832–4370832. 5 indexed citations
12.
Jin, Hong, Yi Zhu, Xiaodong Wang, et al.. (2020). BDNF corrects NLRP3 inflammasome-induced pyroptosis and glucose metabolism reprogramming through KLF2/HK1 pathway in vascular endothelial cells. Cellular Signalling. 78. 109843–109843. 51 indexed citations
13.
Li, Linqing, Erfei Luo, Yong Qiao, et al.. (2020). Hypoxia-induced PINK1/Parkin-mediated mitophagy promotes pulmonary vascular remodeling. Biochemical and Biophysical Research Communications. 534. 568–575. 27 indexed citations
14.
Wang, Dong, Erfei Luo, Jiantong Hou, et al.. (2020). Role of TG2-Mediated SERCA2 Serotonylation on Hypoxic Pulmonary Vein Remodeling. Frontiers in Pharmacology. 10. 1611–1611. 23 indexed citations
15.
Qin, Yuhan, Gaoliang Yan, Yong Qiao, et al.. (2020). Predictive value of random blood glucose versus fasting blood glucose on in-hospital adverse events in patients with ST-segment elevation acute myocardial infarction. BMC Cardiovascular Disorders. 20(1). 95–95. 9 indexed citations
16.
Tang, Chengchun, Jiantong Hou, Gaoliang Yan, et al.. (2019). Effects of Serum Cytochrome c on Contrast-Induced Nephropathy in Patients with ST-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention. BioMed Research International. 2019. 1–6. 3 indexed citations
17.
Tang, Chengchun, Erfei Luo, Dong Wang, et al.. (2019). Usefulness of Haemoglobin Level Combined with CAMI-STEMI Score for Predicting MACCE in Patients with Acute ST-Elevation Myocardial Infarction after PCI. BioMed Research International. 2019. 1–8. 6 indexed citations
18.
Luo, Erfei, Dong Wang, Gaoliang Yan, et al.. (2019). High triglyceride–glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention. Cardiovascular Diabetology. 18(1). 150–150. 189 indexed citations
19.
Luo, Erfei, Dong Wang, Gaoliang Yan, et al.. (2019). The NF-κB/miR-425-5p/MCT4 axis: A novel insight into diabetes-induced endothelial dysfunction. Molecular and Cellular Endocrinology. 500. 110641–110641. 27 indexed citations
20.
Wu, Miaozong, Hongxia Li, Siqi Dong, et al.. (2015). Baicalin Attenuates High Fat Diet-Induced Obesity and Liver Dysfunction: Dose-Response and Potential Role of CaMKKβ/AMPK/ACC Pathway. Cellular Physiology and Biochemistry. 35(6). 2349–2359. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiantong Hou Breakdown of academic impact, for papers by Bernd Hewing Breakdown of academic impact, for papers by Eiichiro Yamamoto Breakdown of academic impact, for papers by Bin Liang Breakdown of academic impact, for papers by Lihua Ni Breakdown of academic impact, for papers by Dachun Xu Breakdown of academic impact, for papers by Yi Song Breakdown of academic impact, for papers by Nada Cordasic Breakdown of academic impact, for papers by Kevin R. Regner Breakdown of academic impact, for papers by Hailing Li
Rankless by CCL
2026